Biora Therapeutics Inc (BIOR)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 80k | 14k | 2k | 2k | 0 | 0 | 542k | 318k |
Operating Income | -13.89M | -13.78M | -15.54M | -14.93M | -23.32M | -13.34M | -15.52M | -15.79M |
Pre Tax Income | -14.72M | -13.21M | -17.44M | -17.8M | -73.45M | -15.73M | -4.14M | 6.4M |
Net Income | -5.11M | -13.72M | -17.44M | -17.81M | -73.45M | -15.41M | -4.19M | 6.47M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -13.89M | -11.16M | -15.63M | -14.94M | -75.43M | -26.62M | -15.3M | -5.89M |
EBITDA | -13.69M | -13.62M | -15.4M | -14.77M | -23.2M | -13.23M | -15.41M | -15.68M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 127.97M | 143.99M | 74.31M | 1.25M | 305k | 4k |
Operating Income | -116.57M | -140.12M | -195.19M | -117.84M | -61.78M | -67.14M |
Pre Tax Income | -123.86M | -148.74M | -230.06M | -178.64M | -49.25M | -124.42M |
Net Income | -129.11M | -228.83M | -192.8M | -247.41M | -38.16M | -124.12M |
Preferred Dividends | 0 | -80.79M | -268k | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -4.506 | -7.442 | -3.457 | -1.36 | -4.274 | -5.236 |
EBIT | -116.57M | -140.12M | -220.08M | -111.85M | -59.16M | -132.61M |
EBITDA | -111.97M | -135.52M | -190.13M | -116.4M | -60.87M | -66.59M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.